On July 23, 2026, analysts from Wolfe Research upgraded AT&T Inc. (T) to an “Outperform” rating, reflecting a positive shift ...
Genmab A/S (GMAB) is catching the attention of investors following a recent upgrade to a Buy rating by Yaron Werber of TD ...
In a notable shift, Morgan Stanley analyst Ronald Kamdem downgraded Vornado Realty Trust (NYSE: VNO) to an “Underweight” ...
John Janedis is an analyst from Wolfe Research specializing in the Communication Services sector. They are beginning to establish their track record, with 1 stock rating so far. Their current stats ...
Utz Brands, Inc. (NYSE: UTZ) recently found itself in the spotlight following an Equal-Weight rating assigned by Andrew Lazar of Barclays on July 21, 2026. The rating indicates a tempered outlook for ...
According to analyst ratings and projections for AEON, AEON Biopharma, Inc. shares are anticipated to decrease by -2.30%, potentially reaching $0.25 per share by August 6, 2026. Short-term technical ...
Andrew Steinerman is an analyst from JP Morgan specializing in the Financial Services sector. Ranked #1878 out of 4742 analysts, they have issued 38 stock ratings with a success rate of 90.25% and an ...
Billy Fitzsimmons is an analyst from Piper Sandler Ranked #349 out of 4732 analysts, they have issued 40 stock ratings with a success rate of 99.42% and an average return of 22.80%. Billy Fitzsimmons ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results